Generic Sweden (OM:GENI) - Stock Price, News & Analysis

GENI Stock Overview

A technology company, provides messaging services for all applications.

GENI fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	4/6
Financial Health	6/6
Dividends	3/6

Rewards

Trading at 16.8% below our estimate of its fair value

Earnings are forecast to grow 16.13% per year

Earnings grew by 7.5% over the past year

Risk Analysis

Unstable dividend track record

Does not have a meaningful market cap (SEK597M)

Generic Sweden AB Competitors

B3 Consulting Group

OM:B3

kr633.2m

Novotek

OM:NTEK B

kr729.3m

CAG Group

OM:CAG

kr763.3m

CombinedX

OM:CX

kr858.9m

Price History & Performance

Summary of all time highs, changes and price drops for Generic Sweden
Historical stock prices
Current Share Price	kr48.60
52 Week High	kr65.40
52 Week Low	kr38.50
Beta	0.93
1 Month Change	2.97%
3 Month Change	8.24%
1 Year Change	18.54%
3 Year Change	-20.07%
5 Year Change	409.43%
Change since IPO	81.34%

Some Confidence Is Lacking In Generic Sweden AB (STO:GENI) As Shares Slide 29%

Feb 25

Generic Sweden's (STO:GENI) Solid Earnings May Rest On Weak Foundations

Feb 22

Recent updates

We Ran A Stock Scan For Earnings Growth And Generic Sweden (STO:GENI) Passed With Ease

Aug 26

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Apr 28

Is It Time To Consider Buying Generic Sweden AB (STO:GENI)?

Apr 08

Is Now The Time To Put Generic Sweden (STO:GENI) On Your Watchlist?

Feb 18

Calculating The Fair Value Of Generic Sweden AB (STO:GENI)

Jan 10

With EPS Growth And More, Generic Sweden (STO:GENI) Is Interesting

Nov 08

Here's Why I Think Generic Sweden (STO:GENI) Is An Interesting Stock

Jul 17

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Apr 13

Is Generic Sweden AB (STO:GENI) A Smart Pick For Income Investors?

Mar 26

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Mar 04

Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Feb 14

Will Weakness in Generic Sweden AB's (STO:GENI) Stock Prove Temporary Given Strong Fundamentals?

Jan 26

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Jan 05

Is There More To The Story Than Generic Sweden's (STO:GENI) Earnings Growth?

Dec 16

Does Generic Sweden AB (STO:GENI) Have A Place In Your Dividend Portfolio?

Nov 25

Shareholder Returns

	GENI	SE IT	SE Market
7D	-4.0%	3.5%	0.6%
1Y	18.5%	2.4%	16.0%

Return vs Industry: GENI exceeded the Swedish IT industry which returned 2.4% over the past year.

Return vs Market: GENI exceeded the Swedish Market which returned 16% over the past year.

Price Volatility

Is GENI's price volatile compared to industry and market?
GENI volatility
GENI Average Weekly Movement	5.9%
IT Industry Average Movement	5.2%
Market Average Movement	5.9%
10% most volatile stocks in SE Market	13.2%
10% least volatile stocks in SE Market	3.5%

Stable Share Price: GENI has not had significant price volatility in the past 3 months.

Volatility Over Time: GENI's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1993	23	Jonas Jegerborn	www.generic.se

Generic Sweden AB, a technology company, provides messaging services for all applications. It also offers a platform for digital communication services. The company was incorporated in 1993 and is headquareted in Stockholm, Sweden.

Generic Sweden AB Fundamentals Summary

How do Generic Sweden's earnings and revenue compare to its market cap?
GENI fundamental statistics
Market cap	kr597.39m
Earnings (TTM)	kr22.98m
Revenue (TTM)	kr150.63m

26.0x

P/E Ratio

4.0x

P/S Ratio

Is GENI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GENI income statement (TTM)
Revenue	kr150.63m
Cost of Revenue	kr111.94m
Gross Profit	kr38.70m
Other Expenses	kr15.72m
Earnings	kr22.98m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.87
Gross Margin	25.69%
Net Profit Margin	15.26%
Debt/Equity Ratio	0%

How did GENI perform over the long term?

See historical performance and comparison

Dividends

3.1%

Current Dividend Yield

79%

Payout Ratio

GENI Stock Overview

Rewards

Risk Analysis

Generic Sweden AB Competitors

OM:B3

kr633.2m

OM:NTEK B

kr729.3m

OM:CAG

kr763.3m

OM:CX

kr858.9m

Price History & Performance

Recent News & Updates

First quarter 2024 earnings: Revenues exceed analyst expectations

Now 23% undervalued

Upcoming dividend of kr1.50 per share

Now 23% undervalued after recent price drop

Some Confidence Is Lacking In Generic Sweden AB (STO:GENI) As Shares Slide 29%

Generic Sweden's (STO:GENI) Solid Earnings May Rest On Weak Foundations

Recent updates

First quarter 2024 earnings: Revenues exceed analyst expectations

Now 23% undervalued

Upcoming dividend of kr1.50 per share

Now 23% undervalued after recent price drop

Some Confidence Is Lacking In Generic Sweden AB (STO:GENI) As Shares Slide 29%

Generic Sweden's (STO:GENI) Solid Earnings May Rest On Weak Foundations

Do Generic Sweden's (STO:GENI) Earnings Warrant Your Attention?

Full year 2023 earnings: EPS misses analyst expectations

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued

Should You Investigate Generic Sweden AB (STO:GENI) At kr60.20?

Investor sentiment improves as stock rises 16%

Now 22% undervalued

Third quarter 2023 earnings: Revenues exceed analyst expectations

Investor sentiment improves as stock rises 21%

Is Now The Time To Look At Buying Generic Sweden AB (STO:GENI)?

New major risk - Earnings quality

Investor sentiment improves as stock rises 17%

Should You Be Adding Generic Sweden (STO:GENI) To Your Watchlist Today?

Upcoming dividend of kr1.25 per share at 2.9% yield

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 21%

Full year 2022 earnings: EPS exceeds analyst expectations

Is Generic Sweden AB (STO:GENI) Potentially Undervalued?

Now 21% undervalued

Now 21% undervalued

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

Second quarter 2022 earnings: Revenues miss analyst expectations

We Ran A Stock Scan For Earnings Growth And Generic Sweden (STO:GENI) Passed With Ease

Investor sentiment deteriorated over the past week

Now 23% undervalued after recent price drop

First quarter 2022 earnings: Revenues miss analyst expectations

Upcoming dividend of kr1.00 per share

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Less than half of directors are independent

Is It Time To Consider Buying Generic Sweden AB (STO:GENI)?

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Now 23% undervalued after recent price drop

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Is Now The Time To Put Generic Sweden (STO:GENI) On Your Watchlist?

Investor sentiment improved over the past week

Calculating The Fair Value Of Generic Sweden AB (STO:GENI)

Investor sentiment deteriorated over the past week

Owner & Member of the board recently sold kr3.5m worth of stock

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Owner & Member of the board recently sold kr3.1m worth of stock

Third quarter 2021 earnings released

With EPS Growth And More, Generic Sweden (STO:GENI) Is Interesting

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released

Investor sentiment improved over the past week

Here's Why I Think Generic Sweden (STO:GENI) Is An Interesting Stock

Owner & Member of the board recently sold kr1.4m worth of stock

Owner & Member of the board recently sold kr1.3m worth of stock